Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (AU1996072664) Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization

Office : Australia
Application Number: 72664/96 Application Date: 22.10.1996
Publication Number: 1996072664 Publication Date: 10.07.1997
Publication Kind : A
Prior PCT appl.: Application Number:AU1996000664 ; Publication Number: Click to see the data
IPC:
A61K 47/36
A61K 48/00
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
36
Polysaccharides; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
48
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applicants: Meditech Research Limited
Inventors:
Agents: Davies Collison Cave Pty Ltd
Priority Data: PN6161 23.10.1995 AU
PN9047 01.04.1996 AU
Title: (EN) Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization
Abstract: front page image
(EN) The invention provides methods and compositions for gene therapy, including antisense therapy. In one embodiment, the compositions comprise hyaluronic acid to promote uptake of nucleic acid by the target cells. The invention is illustrated with reference to treatment of retinal diseases caused by neovascularisation.
Also published as:
SG53164EP0859636JP2000507915CN1209068CA2235685KR1019990066967
NZ320006WO/1997/015330